Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.
Ermine, Charlotte M
Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis. [electronic resource] - Hippocampus 05 2018 - 327-337 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-1063
10.1002/hipo.22835 doi
Adrenergic Neurons--metabolism
Animals
Brain--metabolism
Bromodeoxyuridine
Cell Death
Dopamine--metabolism
Dopamine beta-Hydroxylase
Dopaminergic Neurons--metabolism
Female
Ki-67 Antigen--metabolism
Nerve Degeneration--metabolism
Neural Stem Cells--metabolism
Neurogenesis--physiology
Norepinephrine--metabolism
Oxidopamine
Parkinsonian Disorders--metabolism
Rats, Sprague-Dawley
Saporins
Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis. [electronic resource] - Hippocampus 05 2018 - 327-337 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-1063
10.1002/hipo.22835 doi
Adrenergic Neurons--metabolism
Animals
Brain--metabolism
Bromodeoxyuridine
Cell Death
Dopamine--metabolism
Dopamine beta-Hydroxylase
Dopaminergic Neurons--metabolism
Female
Ki-67 Antigen--metabolism
Nerve Degeneration--metabolism
Neural Stem Cells--metabolism
Neurogenesis--physiology
Norepinephrine--metabolism
Oxidopamine
Parkinsonian Disorders--metabolism
Rats, Sprague-Dawley
Saporins